







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Balendran et al. 274 (52): 37400</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Wyatt%20Ad&url=http://www.wyatt.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/998337801.gif" ALT="Wyatt Technology Corporation"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol274/issue52/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F274%2F52%2F37400">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 





 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/274/52/37400">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/274/52/37400">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;274/52/37400">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/274/52/37400&title=Evidence+That+3-Phosphoinositide-dependent+Protein+Kinase-1+Mediates+Phosphorylation+of+p70+S6+Kinase+in+Vivo+at+Thr-412+as+well+as+Thr-252">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;274/52/37400&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10601311&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10601311&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Balendran+A&link_type=AUTHORSEARCH">Balendran, A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Alessi+DR&link_type=AUTHORSEARCH">Alessi, D. R.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;274/52/37400&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F274%2F52%2F37400"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;274/52/37400">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">
<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


<P>
<FONT SIZE=-1>J Biol Chem, Vol. 274, Issue 52, 37400-37406, December 24, 1999</FONT><BR>




<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    <BR>
    Evidence That 3-Phosphoinositide-dependent Protein
Kinase-1 Mediates Phosphorylation of p70 S6 Kinase <I>in Vivo</I>
at  Thr-412 as well as Thr-252<A HREF="#FN150"><SUP>*</SUP></A>


</H2>



<STRONG>
<NOWRAP>
Anudharan 
Balendran<SUP><IMG SRC="/math/12pt/normal/scr/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>,<WBR>
Richard 
Currie<SUP>&#167;</SUP>,<WBR>
Christopher G. 
Armstrong<SUP>&#182;</SUP>,<WBR>
Joeseph 
Avruch<SUP><IMG SRC="/content/vol274/issue52/fulltext/37400/img001.gif" 
	 ALT="&par;"></SUP>, and<WBR>
Dario R. 
Alessi<SUP><IMG SRC="/math/12pt/normal/scr/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP><A HREF="#FN160"><SUP>**</SUP></A>
</NOWRAP>
</STRONG>
<P>
From the <SUP><IMG SRC="/math/12pt/normal/scr/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>&nbsp;Medical Research Council Protein
Phosphorylation Unit, Department of Biochemistry, University of Dundee,
Dundee DD1 5EH, Scotland, the <SUP>&#167;</SUP>&nbsp;Department of
Biochemistry, University of Dundee, Dundee DD1 5EH, Scotland,
the <SUP>&#182;</SUP>&nbsp;Division of Signal Transduction Therapy Unit, Department of
Biochemistry, University of Dundee, Dundee DD1 5EH, Scotland, and
the <SUP><IMG SRC="/content/vol274/issue52/fulltext/37400/img001.gif" 
	 ALT="&par;"></SUP>&nbsp;Diabetes Unit and Medical Services, Massachusetts General
Hospital, Harvard Medical School, Boston, Massachusetts 02129
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<A NAME="Abstract"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Protein kinase B and p70 S6 kinase are members of
the cyclic AMP-dependent/cyclic GMP-dependent/protein kinase C
subfamily<SUP> </SUP>of protein kinases and are activated by a
phosphatidylinositol<SUP> </SUP>3-kinase-dependent pathway when cells
are stimulated with insulin<SUP> </SUP>or growth factors. Both of these kinases
are activated in cells<SUP> </SUP>by phosphorylation of a conserved residue in the
kinase domain<SUP> </SUP>(Thr-308 of protein kinase B (PKB</A>) and Thr-252 of p70 S6
kinase)<SUP> </SUP>and another conserved residue located C-terminal to the kinase<SUP> </SUP>domain (Ser-473 of PKB</A> and Thr-412 of p70 S6 kinase). Thr-308<SUP> </SUP>of PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
and Thr-252 of p70 S6 kinase are phosphorylated by
3-phosphoinositide-dependent<SUP> </SUP>protein kinase-1 (PDK1</A>)
<I>in vitro</I>. Recent work has shown that PDK1</A><SUP> </SUP>interacts with a
region of protein kinase C-related kinase-2,<SUP> </SUP>termed the PDK1</A>
interacting fragment (PIF</A>). Interaction with PIF</A><SUP> </SUP>converts PDK1</A> from a
form that phosphorylates PKB</A> at Thr-308 alone<SUP> </SUP>to a species capable of
phosphorylating Ser-473 as well as Thr-308.<SUP> </SUP>This suggests that PDK1</A> may
be the enzyme that phosphorylates<SUP> </SUP>both residues <I>in vivo</I>.
Here we demonstrate that PDK1</A> is capable<SUP> </SUP>of phosphorylating p70 S6
kinase at Thr-412 <I>in vitro</I>. We study<SUP> </SUP>the effect of PIF</A> on
the ability of PDK1</A> to phosphorylate p70<SUP> </SUP>S6 kinase. Surprisingly, we
find that PDK1</A> bound to PIF</A> is no<SUP> </SUP>longer able to interact with or
phosphorylate p70 S6 kinase <I>in<SUP> </SUP>vitro</I> at either Thr-252 or
Thr-412. The expression of PIF</A> in cells<SUP> </SUP>prevents insulin-like growth
factor 1&nbsp;from inducing the activation<SUP> </SUP>of the p70 S6 kinase and its
phosphorylation at Thr-412. Overexpression<SUP> </SUP>of PDK1</A> in cells induces the
phosphorylation of p70 S6 kinase<SUP> </SUP>at Thr-412 in unstimulated cells, and
a catalytically inactive<SUP> </SUP>mutant of PDK1</A> prevents the phosphorylation of
p70 S6K at Thr-412<SUP> </SUP>in insulin-like growth factor 1-stimulated cells.
These observations<SUP> </SUP>indicate that PDK1</A> regulates the activation of p70
S6 kinase and<SUP> </SUP>provides evidence that PDK1</A> mediates the phosphorylation
of p70<SUP> </SUP>S6 kinase at Thr-412.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<A NAME="Introduction"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>p70 S6 kinase (p70 S6K)<SUP>1</SUP>
is activated by insulin and growth factors and mediates the
phosphorylation of the 40&nbsp;S ribosomal<SUP> </SUP>protein S6 (<A HREF="#B1">1</A>). This enables
efficient translation of mRNA<SUP> </SUP>molecules containing a polypyrimidine
tract at their 5'-transcriptional<SUP> </SUP>start sites (<A HREF="#B2">2</A>). p70 S6K also
phosphorylates unknown proteins<SUP> </SUP>to permit progression through the
G<SUB>1</SUB> phase of the cell cycle (<A HREF="#B3">3</A>).
</P>
<P>p70 S6K is activated by insulin and growth factors, through a
phosphoinositide 3-kinase-dependent pathway and becomes
phosphorylated<SUP> </SUP>on at least 7&nbsp;Ser/Thr residues in response to these
agonists.<SUP> </SUP>The phosphorylation of two of these residues namely Thr-252
and<SUP> </SUP>Thr-412 on the longer splice variant of the <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-isoform (Thr-229<SUP> </SUP>and Thr-389 on the shorter splice variant) appears to make the<SUP> </SUP>most
important contribution to the activation of p70 S6K (<A HREF="#B4">4-6</A>).<SUP> </SUP>Phosphorylation of Thr-252 alone or mutation of Thr-412 to glutamic<SUP> </SUP>acid to mimic phosphorylation of this residue results in a small<SUP> </SUP>activation of p70 S6K. In contrast, phosphorylation of both residues<SUP> </SUP>or
phosphorylation of Thr-252 in the T412E mutant of p70 S6K results<SUP> </SUP>in a
large activation of expressed p70 S6K, showing that phosphorylation<SUP> </SUP>of
Thr-252 and Thr-412 leads to a synergistic activation p70 S6K<SUP> </SUP>(<A HREF="#B7">7</A>,
<A HREF="#B8">8</A>).
</P>
<P>p70 S6K is a member of the AGC subfamily of protein kinases, which
include protein kinase B (PKB</A>) (<A HREF="#B9">9</A>), protein kinase C<SUP> </SUP>(PKC</A>) isoforms
(<A HREF="#B10">10</A>), and serum- and glucocorticoid-regulated<SUP> </SUP>protein kinase (<A HREF="#B11">11</A>). The
residues surrounding Thr-252 and Thr-412<SUP> </SUP>of p70 S6K are highly
conserved in all AGC family members, and<SUP> </SUP>phosphorylation of the
residues equivalent to Thr-252 and Thr-412<SUP> </SUP>of p70 S6K is necessary for
activation and/or stability of these<SUP> </SUP>kinases <I>in vivo</I> (<A HREF="#B12">12</A>).
Thr-252 is located between subdomains<SUP> </SUP>VII and VIII of the kinase
domain, a region whose phosphorylation<SUP> </SUP>activates many kinases. The
residue equivalent to Thr-252 lies<SUP> </SUP>in a
<U>Thr</U>-Phe-Cys-Gly-Thr-Xaa-Glu-Tyr consensus motif (where the<SUP> </SUP>underlined Thr corresponds to Thr-252 and Xaa is a variable residue).<SUP> </SUP>Thr-412 is located C-terminal to the catalytic domain, and the<SUP> </SUP>residues
surrounding Thr-412 lie in a
Phe-Xaa-Xaa-Phe-<U>Ser/Thr</U>-Phe/Tyr<SUP> </SUP>consensus<SUP> </SUP>motif.
</P>
<P>We (<A HREF="#B7">7</A>) and others (<A HREF="#B8">8</A>) have demonstrated that
3-phosphoinositide-dependent protein kinase-1 (PDK1</A>) (<A HREF="#B13">13</A>)
can phosphorylate<SUP> </SUP>p70 S6K at Thr-252 <I>in vitro</I> and in
transfection experiments. Phosphorylation<SUP> </SUP>of p70 S6K by PDK1</A> <I>in
vitro</I> is independent of the presence of<SUP> </SUP>inositol 3,&nbsp;4,&nbsp;5&nbsp;trisphosphate, and activation is increased greatly<SUP> </SUP>if the noncatalytic
C-terminal tail of p70 S6K is deleted and<SUP> </SUP>if Thr-412 is mutated to an
acidic residue. Other studies have<SUP> </SUP>shown that PDK1</A> phosphorylates the
residue equivalent to Thr-252<SUP> </SUP>of p70 S6K in PKB</A> isoforms (<A HREF="#B14">14</A>, <A HREF="#B15">15</A>), PKC</A>
isoforms (<A HREF="#B16">16-18</A>),<SUP> </SUP>serum- and glucocorticoid-regulated protein kinase
(<A HREF="#B19">19</A>, <A HREF="#B20">20</A>),<SUP> </SUP>and cAMP-dependent protein kinase (<A HREF="#B21">21</A>).
</P>
<P>Recently, we made the surprising observation that PDK1</A> can be converted
from a form that phosphorylates Thr-308 of PKB</A> alone<SUP> </SUP>(the residue
equivalent to Thr-252 in p70 S6K) to a form that<SUP> </SUP>phosphorylates both
Thr-308 and Ser-473 (the residue equivalent<SUP> </SUP>to Thr-412 in p70 S6K)
through interaction with a region of protein<SUP> </SUP>kinase C-related kinase-2
(PRK2</A>), termed the PDK1</A> interacting<SUP> </SUP>fragment (PIF</A>) (<A HREF="#B22">22</A>). In this study,
we sought to identify the<SUP> </SUP>effect that PIF</A> had on the ability of PDK1</A> to
phosphorylate and<SUP> </SUP>activate p70 S6K. Surprisingly, we find that, in
contrast to PKB</A>,<SUP> </SUP>PDK1</A> complexed to PIF</A> can no longer phosphorylate p70
S6K <I>in vitro</I>.<SUP> </SUP>We also report that expression of PIF</A> or a
catalytically inactive<SUP> </SUP>mutant of PDK1</A> in cells prevents the activation
of p70 S6K and<SUP> </SUP>its phosphorylation at Thr-412 as well as Thr-252,
suggesting<SUP> </SUP>that PDK1</A> may mediate the phosphorylation of both residues
<I>in<SUP> </SUP>vivo</I>.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Materials--</I>

The peptides used to assay PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> (RPRAATF) (<A HREF="#B23">23</A>)
and p70 S6K (GRPRTSSFAEG) (<A HREF="#B24">24</A>) and the peptides used to raise and
purify<SUP> </SUP>the T412-P antibody were synthesized by Dr. G.&nbsp;Blomberg
(University<SUP> </SUP>of Bristol, United Kingdom). Protein G-Sepharose,
glutathione-Sepharose,<SUP> </SUP>and CHX-Sepharose were purchased from Amersham
Pharmacia Biotech;<SUP> </SUP>protease inhibitor tablets were from Roche Molecular
Biochemicals,<SUP> </SUP>tissue culture reagents, IGF1, and microcystin-LR were
from Life<SUP> </SUP>Technologies, Inc.; sensorChips CM5 and SA were from BiaCore
AB;<SUP> </SUP>biotinylated reagent and secondary antibodies coupled to horse<SUP> </SUP>radish peroxidase were from<SUP> </SUP>Pierce.



    

    


<P><I>Antibodies--</I>

The phospho-specific antibody recognizing p70
S6K phosphorylated at Thr-412 was raised in sheep against the peptide
SESANQVFLGF<U>T</U>YVAPSV<SUP> </SUP>(corresponding to residues 401-418 of
the longer splice variant<SUP> </SUP>of human <IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">-isoform of p70 S6K), in which
the underlined residue<SUP> </SUP>is phosphothreonine. The antibody was affinity
purified on CH-Sepharose<SUP> </SUP>covalently coupled to the phosphorylated
peptide. The antibodies<SUP> </SUP>were then passed through a column coupled to
the nonphosphorylated<SUP> </SUP>peptide, and the antibodies that did not bind to
this column were<SUP> </SUP>selected. Monoclonal antibodies recognizing the HA</A> or
Myc epitope<SUP> </SUP>were purchased from Roche Molecular Biochemicals; the
monoclonal<SUP> </SUP>antibody recognizing GST</A> was purchased from Sigma and used
to<SUP> </SUP>verify the level of expression of GST-PIF in cells, whereas rabbit<SUP> </SUP>polyclonal antibodies recognizing the 18&nbsp;C-terminal residues of<SUP> </SUP>PRK2/PIF were purchased from Santa Cruz<SUP> </SUP>Biotechnology.



    

    


<P><I>Preparation of Insect Cell His-p70 S6K--</I>

p70 S6K with a His
epitope tag at its N terminus lacking the C-terminal 104&nbsp;residues is
termed p70 S6K-T2. To prepare wild<SUP> </SUP>type and the mutant 412E-p70 S6K-T2
the cDNA for these constructs<SUP> </SUP>was amplified by polymerase chain
reaction from the pMT2 vector<SUP> </SUP>encoding these forms of p70 S6K (<A HREF="#B6">6</A>) using
the following oligonucleotides:<SUP> </SUP>5'-AGG ATC CAC CAT GCA CCA TCA CCA TCA
CCA TAT GAG GCG AGC AAG<SUP> </SUP>GAG GCG G-3' and 5'-GCG GCC GCT CAA CTT TCA AGT
ACA GAT GGA GCC-3'.<SUP> </SUP>The polymerase chain reaction products were then
subcloned into<SUP> </SUP>the <I>Bam</I>HI/<I>Not</I>I sites of the
pFASTBAC 1&nbsp;vector, and this vector<SUP> </SUP>was used to generate recombinant
baculovirus using the Bac-to-Bac<SUP> </SUP>system (Life Technologies, Inc.). The
resulting viruses encoded<SUP> </SUP>p70 S6K-T2 or 412E-p70 S6K-T2 with an
N-terminal hexahistidine<SUP> </SUP>sequence and was used to infect Sf21
cells (1.5&nbsp;&#215;&nbsp;106/ml) at a<SUP> </SUP>multiplicity of infection of 5.&nbsp;The
infected cells were harvested<SUP> </SUP>72&nbsp;h post-infection, and the His-p70
S6K proteins purified by<SUP> </SUP>Ni<SUP>2+</SUP>/nitrilotriacetic acid-agarose
chromatography as described previously<SUP> </SUP>for PKB<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> (<A HREF="#B25">25</A>). They were then
dialyzed against 50&nbsp;m<font size=-1>M</font> Tris/HCl,<SUP> </SUP>pH 7.5,&nbsp;0.1&nbsp;m<font size=-1>M</font>
EGTA, 0.27&nbsp;<font size=-1>M</font> sucrose, 0.03% (by volume) Brij-35,<SUP> </SUP>0.1% (by
volume) 2-mercaptoethanol, 1&nbsp;m<font size=-1>M</font> benzamidine, and 0.2<SUP>&nbsp;</SUP>m<font size=-1>M</font> phenylmethylsulphonyl fluoride, snap frozen in aliquots,
and<SUP> </SUP>stored at <IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">80&nbsp;&#176;C. p70 S6K-T2 or 412E p70 S6K-T2 were both
recovered<SUP> </SUP>with a yield of 60&nbsp;mg/liter infected Sf21 cells and
were &gt;90%<SUP> </SUP>homogeneous as judged by polyacrylamide gel electrophoresis
followed<SUP> </SUP>by Coomassie Blue<SUP> </SUP>staining.



    

    


<P><I>Phosphorylation of GST-p70 S6K by PDK1--</I>

GST-PIF and
GST-D978A-PIF were expressed in human embryonic kidney 293&nbsp;cells and
purified on glutathione-Sepharose, and the<SUP> </SUP>very small amount of
endogenous PDK1</A> associated with GST-PIF was<SUP> </SUP>removed by
immunoprecipitation with a PDK1</A> antibody (<A HREF="#B22">22</A>). Phosphorylation<SUP> </SUP>of
GST-p70 S6K-T2 by PDK1</A> was carried out as described previously<SUP> </SUP>(<A HREF="#B7">7</A>)
except that PDK1</A> was incubated with the indicated concentration<SUP> </SUP>of
GST-PIF or PIF</A> peptide for 10&nbsp;min on ice prior to initiation<SUP> </SUP>of the
assay with magnesium [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP. The wild type GST-p70
S6K-T2, and the mutant T252A-GST-p70<SUP> </SUP>S6K-T2, T412A-GST-p70 S6K-T2
proteins were expressed in 293&nbsp;cells<SUP> </SUP>and purified as described
previously (<A HREF="#B7">7</A>). Wild type and catalytically<SUP> </SUP>inactive GST-PDK1 were
expressed either in 293&nbsp;cells (<A HREF="#B26">26</A>) or<SUP> </SUP>in <I>Escherichia
coli</I> (<A HREF="#B27">27</A>).



    

    


<P><I>Transient Transfection Experiments--</I>

The DNA constructs
encoding for the wild type and mutant forms of HA-p70 S6K in the pMT2
vector used in this study have been<SUP> </SUP>described previously (<A HREF="#B6">6</A>). The
constructs encoding wild type<SUP> </SUP>HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> (<A HREF="#B25">25</A>), wild type Myc-PDK1 (<A HREF="#B26">26</A>),
and a catalytically<SUP> </SUP>inactive mutant of Myc-PDK1 (in which Lys-111 and
Asp-223 are<SUP> </SUP>both mutated to Ala), termed "kinase-dead" PDK1</A> (<A HREF="#B26">26</A>),
were all<SUP> </SUP>in the pCMV5 vector. The constructs used to express GST-PIF
and<SUP> </SUP>the mutant GST-F977A-PIF (<A HREF="#B22">22</A>) are in the pEBG2T vector. The<SUP> </SUP>empty
pEBG2T vector was used to express GST</A> protein in control<SUP> </SUP>experiments.
DNA constructs used in this study were purified from<SUP> </SUP>bacteria using the
Qiagen plasmid Mega kit according to the manufacturer's<SUP> </SUP>protocol.
<P>
293 cells cultured on 10-cm diameter dishes in Dulbecco's modified
Eagle's medium containing 10% (by volume) fetal bovine<SUP> </SUP>serum were
transfected with 2&nbsp;&#181;g of DNA construct encoding either<SUP> </SUP>wild type or
mutant HA-p70 S6K or HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and 10&nbsp;&#181;g of DNA construct<SUP> </SUP>encoding
GST-PIF, GST-F977A-PIF, GST</A>, Myc-PDK1, kinase-dead Myc-PDK1,<SUP> </SUP>or the
empty pCMV5 vector using a modified calcium phosphate method<SUP> </SUP>(<A HREF="#B28">28</A>).
24&nbsp;h posttransfection the cells were deprived of serum<SUP> </SUP>for 16&nbsp;h and exposed to IGF1 (100&nbsp;n<font size=-1>M</font>) for the time indicated.<SUP> </SUP>The
cells were lysed in 1&nbsp;ml of lysis buffer (50&nbsp;m<font size=-1>M</font> Tris/HCl,<SUP> </SUP>pH 7.5,&nbsp;1&nbsp;m<font size=-1>M</font> EDTA, 1&nbsp;m<font size=-1>M</font> EGTA, 1% (by volume)
Triton X-100, 1&nbsp;m<font size=-1>M</font><SUP> </SUP>sodium orthovanadate, 10&nbsp;m<font size=-1>M</font>
sodium <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-glycerophosphate, 50&nbsp;m<font size=-1>M</font> NaF,<SUP> </SUP>5&nbsp;m<font size=-1>M</font>
sodium pyrophosphate, 1&nbsp;&#181;<font size=-1>M</font> microcystin-LR, 0.27&nbsp;<font size=-1>M</font> sucrose,<SUP> </SUP>and protease inhibitor tablets) and cleared by
centrifugation,<SUP> </SUP>and 50&nbsp;&#181;g of protein was subjected to
immunoprecipitation with<SUP> </SUP>anti-HA monoclonal antibody. The protein
concentrations of the<SUP> </SUP>lysates were determined by the Bradford<SUP> </SUP>method.



    

    


<P><I>Kinase Assays--</I>

The HA-p70 S6K or HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
immunoprecipitates were washed and assayed for kinase activity using
the peptide Crosstide (GRPRTSSFAEG)<SUP> </SUP>as described previously for PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
(<A HREF="#B28">28</A>). One unit of activity<SUP> </SUP>was the amount that catalyzed the
phosphorylation of 1&nbsp;nmol of<SUP> </SUP>substrate in 1<SUP>&nbsp;</SUP>min.



    

    


<P><I>Immunoblotting for Dephosphorylated and Thr-412-phosphorylated
p70 S6 Kinase--</I>

Cell lysates were made with 1% SDS, and the
indicated amounts of protein were subjected to SDS-polyacrylamide gel
electrophoresis,<SUP> </SUP>subsequently transferred to nitrocellulose, and
immunoblotted<SUP> </SUP>using the indicated monoclonal antibody or the T412-P
phospho-specific<SUP> </SUP>antibody (0.&nbsp;4&nbsp;&#181;g/ml) in 50&nbsp;m<font size=-1>M</font> Tris/HCl,
pH 7.5,&nbsp;0.15&nbsp;<font size=-1>M</font> NaCl,<SUP> </SUP>0.5% (by volume) Tween, and 10% (by
mass) skimmed milk. Detection<SUP> </SUP>was performed using the enhanced
chemiluminescence reagent (Amersham<SUP> </SUP>Pharmacia<SUP> </SUP>Biotech).



    

    


<P><I>Surface Plasmon Resonance Measurements of PDK1</A> Binding to p70 S6
Kinase--</I>

p70 S6K-T2 and T412E p70 S6K-T2 mutant were amine-coupled
to a CM5 sensor chip (BIAcore AB) according to the manufacturer's<SUP> </SUP>instructions. The indicated concentrations of His-PDK1 were injected<SUP> </SUP>over the chip at a flow rate of 30&nbsp;&#181;l/min, and the steady-state<SUP> </SUP>binding was determined in the presence or absence of PIF</A> peptide.<SUP> </SUP>The
apparent equilibrium dissociation constant (<I>K</I><SUB><I>d</I></SUB>) for<SUP> </SUP>the binding of His-PDK1 to p70 S6 kinase was determined by fitting<SUP> </SUP>the
increase in steady-state binding upon increasing PDK1</A> concentration<SUP> </SUP>to
a rectangular hyperbola using SigmaPlot 4&nbsp;(SPSS Inc.). The<SUP> </SUP>measure of
response in our experiments is termed RU; 1000&nbsp;RU&nbsp;=<SUP>&nbsp;</SUP>1&nbsp;ng/mm<SUP>2</SUP> of protein bound to the<SUP> </SUP>surface.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Phosphorylation of p70 S6K by PDK1</A> Is Inhibited by PIF--</I>

PDK1</A>
binds with submicromolar affinity to a region of PRK2</A> termed PIF</A> (<A HREF="#B22">22</A>).
PIF</A> is situated C-terminal to the kinase domain<SUP> </SUP>of PRK2</A>, and the
binding of this region of PRK2</A> to PDK1</A> is mediated<SUP> </SUP>by a consensus motif
similar to that encompassing Thr-412 of p70<SUP> </SUP>S6K, except that the
residue at this position is Asp (Asp-978),<SUP> </SUP>rather than Thr or Ser. In
Fig. <a href="#F1">1</a>, we demonstrate that PDK1</A>, when<SUP> </SUP>complexed to either GST-PIF or a 24&nbsp;residue synthetic peptide<SUP> </SUP>whose
sequence encompasses the PDK1</A> binding site on PIF</A>, was unable<SUP> </SUP>to
phosphorylate GST-p70 S6K-T2 (a deletion mutant of p70 S6K<SUP> </SUP>that lacks
the C-terminal 104&nbsp;residues) <I>in vitro</I>. In a parallel<SUP> </SUP>experiment it was verified that PDK1</A> complexed to GST-PIF or the<SUP> </SUP>PIF</A>
peptide was able to phosphorylate PKB</A> at both Thr-308 and<SUP> </SUP>Ser-473 to
near stoichiometric levels (data not shown) as reported<SUP> </SUP>previously
(<A HREF="#B22">22</A>). GST-p70 S6K-T2 was used as a PDK1</A> substrate<SUP> </SUP>(Fig. <a href="#F1">1</a>) rather than
the full-length p70 S6K, which is very poorly<SUP> </SUP>phosphorylated by PDK1</A>
<I>in vitro</I> (<A HREF="#B7">7</A>, <A HREF="#B8">8</A>). Truncation of the<SUP> </SUP>C-terminal 104&nbsp;residues
of p70 S6K is likely to be benign, as<SUP> </SUP>p70 S6K-T2 2&nbsp;when expressed in
cells possesses indistinguishable<SUP> </SUP>properties to the full-length protein
as it is still activated<SUP> </SUP>by insulin and growth factors in a rapamycin-
and wortmannin-sensitive<SUP> </SUP>manner (<A HREF="#B5">5</A>, <A HREF="#B6">6</A>).



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=131 SRC="/content/vol274/issue52/images/small/bc4993497001.gif"></A><BR>

<STRONG>View larger version</STRONG> (21K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F1"
onClick="startTarget('F1', 590, 489); this.href='/cgi/content-nw/full/274/52/37400/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>PIF</B></A><B> prevents </B><B>PDK1</B></A><B> from phosphorylating p70
S6K <I>in vitro</I>.</B> GST-p70 S6K lacking the C-terminal
104&nbsp;amino acids (GST-p70 S6KT2) (1&nbsp;&#181;g) was incubated for 30&nbsp;min at
30&nbsp;&#176;C with magnesium [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP and GST-PDK1 (50&nbsp;n<font size=-1>M</font>) in the presence or absence of either wild type
(<I>wt</I>) GST-PIF or D978A GST-PIF (1.5&nbsp;&#181;<font size=-1>M</font>) or the
indicated PIF</A> peptides (4&nbsp;&#181;<font size=-1>M</font>) in a final volume of 20&nbsp;&#181;l. The reactions were terminated by making the solutions 1% in SDS;
the samples were subjected to SDS-polyacrylamide gel electrophoresis,
and the phosphorylation was assessed by autoradiography of the gel. The
position in the gel where GST-p70 S6KT2 (73&nbsp;kDa) migrates is indicated
with an <I>arrow</I>. The only other <SUP>32</SUP>P-labeled
protein on the gel, which is not shown, corresponded to
autophosphorylation of PDK1</A> and contained ~10-fold lower levels
of<SUP> 32</SUP>P radioactivity than that of the GST-p70 S6T2
phosphorylated by PDK1</A> in the absence of PIF</A>. A high amount of PDK1</A> is
used in this experiment to achieve a near maximal phosphorylation of
GST-p70 S6T2. If the reactions were carried out at a 10-fold lower
concentration of PDK1</A> under conditions where the phosphorylation of
GST-p70 S6T2 by PDK1</A> is linear with time and the amount of substrate
used, then PIF</A> still prevented the phosphorylation of GST-p70 S6KT2
(data not shown). <I>wt</I> indicates wild type, and
<I>PSer</I> indicates phosphoserine. The results of a duplicate
experiment for each condition are shown, and similar findings were
obtained in five separate experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->




<P>
A mutant form of GST-PIF or the 24-residue PIF</A> peptide in which the
amino acid equivalent to Asp-978 in PRK2</A> is mutated to<SUP> </SUP>Ala
(GST-D978A-PIF) possesses markedly reduced affinity for PDK1</A><SUP> </SUP>(<A HREF="#B22">22</A>).
Consistent with this, GST-D978A-PIF or the mutant D978A-PIF<SUP> </SUP>peptide
poorly inhibited the phosphorylation of GST-p70 S6K-T2<SUP> </SUP>by PDK1</A> (Fig.
<a href="#F1">1</a>). If Asp-978 in the PIF</A> peptide is mutated to<SUP> </SUP>a phosphoserine residue
instead of an Ala, to restore the negative<SUP> </SUP>charge, the resulting
peptide interacted with PDK1</A> with the same<SUP> </SUP>affinity as the wild type
PIF</A> peptide (<A HREF="#B22">22</A>) and prevented PDK1</A><SUP> </SUP>from phosphorylating GST-p70 S6K-T2
(Fig. <a href="#F1">1</a>).



    

    


<P><I>PDK1</A> Phosphorylates p70 S6 Kinase at Thr-412 in Vitro--</I>

To
determine whether PDK1</A> could phosphorylate p70 S6K at Thr-412, we
raised phospho-specific antibodies that only recognize<SUP> </SUP>p70 S6K
phosphorylated at Thr-412 (termed T412-P antibody). This<SUP> </SUP>antibody did
not recognize GST-p70 S6K-T2 that had been incubated<SUP> </SUP>with magnesium ATP
in the absence of PDK1</A>. However, following<SUP> </SUP>the addition of PDK1</A>, which
had either been expressed in 293&nbsp;cells<SUP> </SUP>or bacteria, the GST-p70 S6K-T2
became recognized by the T412-P<SUP> </SUP>antibody (Fig.
<a href="#F2">2</a>). Incubation of the T412-P antibody
with the<SUP> </SUP>phosphorylated Thr-412 peptide immunogen used to raise the
antibody<SUP> </SUP>(but not with the dephosphorylated peptide) abolished its
recognition<SUP> </SUP>of GST-p70 S6K-T2 (see Fig.
<a href="#F3">3</a>). The rate at which PDK1</A> phosphorylated<SUP> </SUP>Thr-412 (as well as Thr-252) of GST-p70 S6K-T2 was not increased<SUP> </SUP>in the
presence of lipid vesicles containing phosphatidylinositol<SUP> </SUP>3,4,5-trisphosphate (data not shown). PDK1</A> phosphorylated the<SUP> </SUP>T252A
mutant of GST-p70 S6K-T2 at Thr-412 to the same extent as<SUP> </SUP>the wild type
GST-p70 S6K-T2. The T412A mutant of GST-p70 S6K-T2<SUP> </SUP>was not recognized
by the T412-P antibody after incubation with<SUP> </SUP>PDK1/magnesium ATP. The
24-residue PIF</A> peptide prevented PDK1</A><SUP> </SUP>from phosphorylating the p70 S6K
at Thr-412. A kinase-dead mutant<SUP> </SUP>of PDK1</A> was unable to phosphorylate
GST-p70 S6K-T2 at Thr-412<SUP> </SUP>(Fig. <a href="#F2">2</a>).



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=35 SRC="/content/vol274/issue52/images/small/bc4993497002.gif"></A><BR>

<STRONG>View larger version</STRONG> (12K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F2"
onClick="startTarget('F2', 590, 278); this.href='/cgi/content-nw/full/274/52/37400/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>PDK1</B></A><B> phosphorylates p70 S6K at Thr-412
<I>in vitro</I> and this is inhibited by </B><B>PIF</B></A><B>.</B> 0.5&nbsp;&#181;g
of wild type GST-p70 S6K-T2 (<I>wt</I>), T252A-GST-p70 S6K-T2
(<I>252A</I>), or T412A-GST-p70 S6K-T2 (<I>412A</I>) were
incubated for 90&nbsp;min at 30&nbsp;&#176;C with magnesium ATP in the presence or
absence of wild type (<I>wt</I>) or kinase-dead (<I>kd</I>)
GST-PDK1 expressed in either 293&nbsp;cells or bacteria in the presence (+)
or absence (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) of the wild type PIF</A> peptides (4&nbsp;&#181;<font size=-1>M</font>) in a
final volume of 20&nbsp;&#181;l. The reactions were terminated by making the
solutions 1% in SDS; the samples were subjected to SDS-polyacrylamide
gel electrophoresis, and the phosphorylation of p70 S6K at Thr-412 was
assessed by immunoblotting with the T-412P antibody. Similar results
were obtained in three separate experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->







<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=174 HEIGHT=200 SRC="/content/vol274/issue52/images/small/bc4993497003.gif"></A><BR>

<STRONG>View larger version</STRONG> (24K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F3"
onClick="startTarget('F3', 532, 640); this.href='/cgi/content-nw/full/274/52/37400/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>PIF</B></A><B> inhibits p70 S6K activation and
phosphorylation at Thr-252 and Thr-412.</B> 293&nbsp;cells were
co-transfected with constructs expressing the wild type (<I>wt</I>)
full-length HA-p70 S6K (<I>A</I>) or the full-length HA-T412E p70
S6K (<I>B</I>) with either GST-PIF, GST-F977A-PIF, or GST</A>. 24&nbsp;h posttransfection the cells were serum-starved for 16&nbsp;h and then
stimulated for 40&nbsp;min with 100&nbsp;n<font size=-1>M</font> IGF1. The cells were
lysed and HA-p70 S6K was immunoprecipitated and assayed as described
under "Experimental Procedures." Protein from each lysate (10&nbsp;&#181;g
for the HA</A> blots or 20&nbsp;&#181;g for the T412-P blot) was electrophoresed on
a 10% SDS/polyacrylamide gel and immunoblotted using HA-antibody or
the T412-P antibody. The T412-P antibody was incubated with either the
synthetic peptide (10&nbsp;&#181;g/ml) corresponding to residues 401&nbsp;to 418&nbsp;of
p70 S6K phosphorylated at Thr-412 (phospho-412E peptide) or the
unphosphorylated peptide (dephospho-Thr-412 peptide). The T412-P
antibody consistently recognizes a protein termed "nonspecific
band" in cell lysates, which migrates at (75&nbsp;kDa) derived from
nontransfected and transfected cells. The intensity of this band does
not change with IGF1. It is not co-immunoprecipitated with HA-p70 S6K
(data not shown). The HA-p70 S6K activities shown are the average&nbsp;&#177;&nbsp;S.E. for a single experiment carried out in triplicate. Similar
result were obtained in eight separate experiments (<I>A</I>) and
two experiments (<I>B</I>).


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->




<P>
The rate at which PDK1</A> phosphorylates Thr-412 is likely to be
significantly lower than that at which it phosphorylates Thr-252.<SUP> 32</SUP>P-labeled GST-p70 S6K-T2 phosphorylated with PDK1</A> was
digested<SUP> </SUP>with either trypsin or V8 protease and then subjected to
peptide<SUP> </SUP>map analysis on HPLC</A> as described previously (<A HREF="#B7">7</A>). This analysis<SUP> </SUP>revealed that the major <SUP>32</SUP>P-labeled peptide containing
~20-30% of the total radioactivity<SUP> </SUP>applied to the HPLC</A> column
corresponded to the peptide phosphorylated<SUP> </SUP>at Thr-252. Although several
minor peptides were present in this<SUP> </SUP>analysis, which each comprised
&lt;5% of the total phosphate, we<SUP> </SUP>were unable to attribute any of these
to a peptide phosphorylated<SUP> </SUP>at Thr-412. This analysis does not exclude
the possibility that<SUP> </SUP>the recovery of the <SUP>32</SUP>P-labeled
peptide phosphorylated at Thr-412 may be poor but suggests<SUP> </SUP>that the
stoichiometry at which PDK1</A> phosphorylated p70 S6K at<SUP> </SUP>Thr-412 is much
lower than that which it phosphorylates Thr-252.



    

    


<P><I>PIF</A> Inhibits IGF1-induced Activation of p70 S6K--</I>

To determine
whether expression of PIF</A> in cells could prevent the endogenous PDK1</A>
from phosphorylating and activating p70<SUP> </SUP>S6K, HA-tagged full-length p70
S6K (HA-p70 S6K) was transfected<SUP> </SUP>into 293&nbsp;cells together with
constructs encoding either GST-PIF,<SUP> </SUP>a mutant form of GST-PIF that
interacts with PDK1</A> weakly (GST-F977A-PIF),<SUP> </SUP>or GST</A> itself. The wild
type or mutant GST-PIF and GST</A> itself<SUP> </SUP>were all expressed at a similar
level and were present at a much<SUP> </SUP>higher concentration than the
endogenous PDK1</A> or PRK2</A> (data not<SUP> </SUP>shown). The cells were subsequently
stimulated with IGF1 for 40<SUP>&nbsp;</SUP>min (the time at which HA-p70 S6K is
maximally activated) (data<SUP> </SUP>not shown); the cells were lysed, and the
HA-p70 S6K was immunoprecipitated<SUP> </SUP>and assayed. Cells expressing HA-p70
S6K and GST</A> exhibited a readily<SUP> </SUP>measurable basal p70 S6K activity in
unstimulated cells, which<SUP> </SUP>was increased 10-fold in response to IGF1
(Fig. <a href="#F3">3</a><I>A</I>). In contrast,<SUP> </SUP>cells expressing HA-p70 S6K and
GST-PIF possessed a basal HA-p70<SUP> </SUP>S6K activity that was virtually
undetectable, and IGF1-stimulation<SUP> </SUP>caused only a very slight increase
in the HA</A> p70 S6K activity<SUP> </SUP>(Fig. <a href="#F3">3</a><I>A</I>). In cells expressing
HA-p70 S6K and GST-F977A-PIF, HA-p70<SUP> </SUP>S6K was substantially activated by
IGF1, although not to the same<SUP> </SUP>extent as in cells expressing HA-p70 S6K
and GST</A> (Fig. <a href="#F3">3</a><I>A</I>). This<SUP> </SUP>is probably explained by a weak
interaction of GST-F977A-PIF with<SUP> </SUP>PDK1</A>.



    

    


<P><I>PIF</A> Inhibits IGF1-induced Phosphorylation of p70 S6K at
Thr-412--</I>

As PIF</A> inhibited p70 S6K activation in cells, we sought
to determine the effect of PIF</A> expression on the phosphorylation of<SUP> </SUP>p70
S6K at Thr-412 and Thr-252. We used the T412-P antibody to<SUP> </SUP>measure the
phosphorylation of p70 S6K at Thr-412. These experiments<SUP> </SUP>showed that
IGF1 triggered the phosphorylation of Thr-412 (Fig.<SUP> </SUP><a href="#F3">3</a><I>A</I>).
This was abolished by incubation of the T412-P antibody with<SUP> </SUP>the
phosphorylated Thr-412 peptide immunogen used to raise the<SUP> </SUP>antibody but
not with the dephosphorylated peptide (Fig. <a href="#F3">3</a><I>A</I>) or<SUP> </SUP>a
phosphopeptide corresponding to the sequence surrounding Thr-252<SUP> </SUP>(data
not shown). Furthermore, a mutant form of HA-p70 S6K in<SUP> </SUP>which Thr-412
was changed to an Ala was not recognized by the<SUP> </SUP>T412-P antibody
following IGF1 stimulation (Fig. <a href="#F5">5</a><I>C</I>).
<P>
When HA-p70 S6K was coexpressed in cells with GST-PIF, IGF1 failed to
induce the phosphorylation of HA-p70 S6K at Thr-412<SUP> </SUP>(Fig.
<a href="#F3">3</a><I>A</I>). In contrast, in cells expressing HA-p70 S6K and the<SUP> </SUP>mutant GST-F977A-PIF, the phosphorylation of HA-p70 S6K still<SUP> </SUP>occurred
but at a lower level than that observed in cells expressing<SUP> </SUP>HA-p70 S6K
and GST</A>. The decrease in Thr-412 phosphorylation is<SUP> </SUP>consistent with the
reduced activation of HA-p70 S6K in these<SUP> </SUP>cells compared with those
expressing GST</A> alone (Fig. <a href="#F3">3</a><I>A</I>). It should<SUP> </SUP>be noted, however,
that cotransfection of HA</A> p70 S6K with the<SUP> </SUP>GST-F977A-PIF mutant induced
a 50% maximal activation of P70 S6K,<SUP> </SUP>despite inducing a significantly
greater reduction in the level<SUP> </SUP>of phosphorylation of Thr-412 (Fig.
<a href="#F3">3</a><I>A</I>). This finding demonstrates<SUP> </SUP>that the relationship between
p70 phosphorylation at Thr-412 and<SUP> </SUP>level of p70 S6K activity does not
appear to be linear. One explanation<SUP> </SUP>for this observation is that the
F977A-PIF mutant may inhibit<SUP> </SUP>more potently p70 S6K phosphorylation at
Thr-412 than Thr-252;<SUP> </SUP>however, thus far we have not been able to raise
phospho-specific<SUP> </SUP>antibodies recognizing p70 S6K phosphorylated at
Thr-252 to explore<SUP> </SUP>this possibility. The overexpression of GST-PIF in
cells also<SUP> </SUP>abolished the IGF1-induced activation and phosphorylation at
Thr-412<SUP> </SUP>of the p70 S6K-T2 mutant, which lacks the C-terminal 104&nbsp;residues<SUP> </SUP>(data not<SUP> </SUP>shown).



    

    


<P><I>PIF</A> Inhibits IGF1-induced Phosphorylation of p70 S6K at
Thr-252--</I>

A mutant form of HA-p70 S6K in which Thr-412 was altered
to glutamic acid to mimic the presence of a phosphorylated residue<SUP> </SUP>at
this position possessed an elevated basal activity that was<SUP> </SUP>further
activated by IGF1 when co-expressed with GST</A> or the mutant<SUP> </SUP>GST-F977A-PIF (Fig. <a href="#F3">3</a><I>B</I>). Previous work has established that
the<SUP> </SUP>basal and IGF1-stimulated activity of this mutant are mediated<SUP> </SUP>through phosphorylation of Thr-252 (<A HREF="#B6">6</A>). In Fig. <a href="#F3">3</a><I>B</I>, we
demonstrate<SUP> </SUP>that co-expression of HA-412E p70 S6K with PIF</A> greatly
reduced<SUP> </SUP>the basal activity of this mutant and largely prevented its
activation<SUP> </SUP>by IGF1. This suggests that PIF</A> also inhibits the
phosphorylation<SUP> </SUP>of p70 S6K at Thr-252. The overexpression of PIF</A> in
cells also<SUP> </SUP>greatly reduced the basal and IGF1-stimulated activity of
T412E<SUP> </SUP>p70 S6K-T2 mutant in cells (data not<SUP> </SUP>shown).



    

    


<P><I>PIF</A> Does Not Inhibit the Activation of PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> or Its
Phosphorylation at Ser-473--</I>

Previous work has shown that PIF</A> does
not prevent PDK1</A> from phosphorylating PKB</A> in the presence of
3-phosphoinositide lipids<SUP> </SUP>but instead enables PDK1</A> to phosphorylate PKB</A>
at both Thr-308<SUP> </SUP>and Ser-473 (see the introduction). Here we show that
in marked<SUP> </SUP>contrast to the effect of GST-PIF on p70 S6K activation,
expression<SUP> </SUP>of GST-PIF in 293&nbsp;cells does not prevent IGF1 from inducing
a<SUP> </SUP>~20-fold activation of HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. This activation is similar to<SUP> </SUP>that observed when HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is coexpressed with GST</A> (Fig.
<a href="#F4">4</a>). Expression<SUP> </SUP>of GST-PIF did not inhibit
or potentiate the IGF1-induced phosphorylation<SUP> </SUP>of HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> at Ser-473
(the residue equivalent to Thr-412 in p70<SUP> </SUP>S6K) (Fig. <a href="#F4">4</a>). GST-PIF is
expressed at a similar level when cotransfected<SUP> </SUP>with PKB</A> and HA-p70 S6K
(data not shown), indicating that the<SUP> </SUP>inability of PIF</A> to affect the
activation of PKB</A> in cells is not<SUP> </SUP>because of it being expressed at a
low level.



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=165 SRC="/content/vol274/issue52/images/small/bc4993497004.gif"></A><BR>

<STRONG>View larger version</STRONG> (29K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F4"
onClick="startTarget('F4', 590, 563); this.href='/cgi/content-nw/full/274/52/37400/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>PIF</B></A><B> does not inhibit </B><B>PKB</B></A><B><IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">
activation or its phosphorylation at Ser-473.</B> 293&nbsp;cells were
co-transfected with constructs expressing the wild type full-length
HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> with either GST-PIF or GST</A>. 24&nbsp;h posttransfection the
cells were serum starved for 16&nbsp;h and then stimulated for 15&nbsp;min
with 100&nbsp;n<font size=-1>M</font> IGF1. The cells were lysed and HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> was
immunoprecipitated and assayed as described under "Experimental
Procedures." Protein from each lysate (10&nbsp;&#181;g) was electrophoresed
on a 10% SDS/polyacrylamide gel and immunoblotted using HA-antibody or
the S473-P antibody. The HA-PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> activities shown are the
averages&nbsp;&#177;&nbsp;S.E. for a single experiment carried out in
triplicate; similar results were obtained in three separate
experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->







    

    


<P><I>A Catalytically Inactive Mutant of PDK1</A> Prevents the Activation and
Phosphorylation of p70 S6K--</I>

Consistent with earlier findings (<A HREF="#B7">7</A>,
<A HREF="#B8">8</A>), co-expression of HA-p70 S6K with wild type PDK1</A> induced a large
activation<SUP> </SUP>of HA</A> p70 S6K, which was not increased further by IGF1
stimulation<SUP> </SUP>(Fig. <a href="#F5">5</a><I>A</I>). We
consistently observed a slight decrease in HA-p70<SUP> </SUP>S6K activity in cells
overexpressing PDK1</A> following IGF1 stimulation.<SUP> </SUP>The co-expression of
wild type PDK1</A> with HA-p70 S6K or T252A-p70<SUP> </SUP>S6K also resulted in a
large increase in Thr-412 phosphorylation<SUP> </SUP>in unstimulated cells (Fig.
<a href="#F5">5</a>, <I>A</I> and <I>B</I>). In contrast, no immunoreactive<SUP> </SUP>band
was detected after immunoblotting with the T412-P antibody<SUP> </SUP>when wild
type PDK1</A> and the HA-T412A p70 S6K mutant were co-expressed<SUP> </SUP>(Fig.
<a href="#F5">5</a><I>C</I>). When a kinase-dead mutant of PDK1</A> was co-expressed<SUP> </SUP>with
HA-p70 S6K, the latter was no longer activated following<SUP> </SUP>IGF1-stimulation of cells nor was it phosphorylated at Thr-412<SUP> </SUP>(Fig.
<a href="#F5">5</a><I>A</I>). In Fig. <a href="#F5">5</a><I>D</I> we demonstrate that co-expression
of HA-412E<SUP> </SUP>p70 S6K with a catalytically inactive PDK1</A> reduced the basal
level<SUP> </SUP>of HA-412E p70 S6K and largely prevented its activation by IGF1.<SUP> </SUP>This provides evidence that overexpression of a kinase-dead PDK1</A><SUP> </SUP>in
cells also inhibits the phosphorylation of p70 S6K at Thr-252.<SUP> </SUP>


<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=130 HEIGHT=200 SRC="/content/vol274/issue52/images/small/bc4993497005.gif"></A><BR>

<STRONG>View larger version</STRONG> (27K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F5"
onClick="startTarget('F5', 437, 640); this.href='/cgi/content-nw/full/274/52/37400/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>A kinase-dead </B><B>PDK1</B></A><B> inhibits p70 S6K
activation and phosphorylation at Thr-252 and Thr-412.</B> 293&nbsp;cells
were co-transfected with constructs expressing the wild type
(<I>wt</I>) full-length HA-p70 S6K (<I>A</I>), full-length
HA-252A p70 S6K (<I>B</I>), full-length HA-412A p70 S6K
(<I>C</I>), or full-length HA-412E p70 S6K (<I>D</I>) with
either wild type PDK1</A>, a kinase-dead (<I>kd</I>) mutant of PDK1</A> or
the empty pCMV5 vector. 24&nbsp;h posttransfection, the cells were
serum-starved for 16&nbsp;h and then stimulated for 40&nbsp;min with 100&nbsp;n<font size=-1>M</font> IGF1. The cells were lysed; wild type and mutant forms
of HA-p70 S6K were immunoprecipitated and assayed as described under
"Experimental Procedures." The HA-252A p70 S6K or the HA-412A p70
S6K is essentially inactive under all conditions as reported previously
(<A HREF="#B6">6</A>) (data not shown). Protein from each lysate (10&nbsp;&#181;g for the HA</A>
blots or 20&nbsp;&#181;g for the T412-P blot) was electrophoresed on a 10%
SDS/polyacrylamide gel and immunoblotted using HA-antibody or the
T412-P antibody. The T412-P antibody was incubated in the presence of
the dephosphorylated peptide corresponding to residues 401-418 of p70
S6K. The HA-p70 S6K activities shown are the average&nbsp;&#177;&nbsp;S.E. for a
single experiment carried out in triplicate. Similar results were
obtained in at least three separate experiments. Comparable results to
the HA</A> and T412-P blots shown were also obtained in at least three
separate experiments.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







    

    


<P><I>PIF</A> Prevents the Interaction of PDK1</A> with p70 S6 Kinase--</I>

A
recent study by Blenis and colleagues (<A HREF="#B29">29</A>) reported that, when PDK1</A> and
p70 S6K were cotransfected into cells, a small<SUP> </SUP>amount of PDK1</A> was
coimmunoprecipitated with p70 S6K, suggesting<SUP> </SUP>that these proteins may
interact directly. Using surface plasmon<SUP> </SUP>resonance measurements, we
were able to detect a significant interaction<SUP> </SUP>(apparent
<I>K</I><SUB><I>d</I></SUB> 8&nbsp;&#181;<font size=-1>M</font>) between PDK1</A> and p412E-p70
S6K-T2<SUP> </SUP>(Fig. <a href="#F6">6</a>). This interaction was
abolished in the presence of the<SUP> </SUP>24-residue wild type PIF</A> peptide but
not the D978A mutant of the<SUP> </SUP>PIF</A> peptide (Fig. <a href="#F6">6</a>), suggesting that both
the PIF</A> and 412E-p70<SUP> </SUP>S6K-T2 mutant compete for the same binding site on
PDK1</A>. In parallel<SUP> </SUP>experiments, a significantly weaker interaction
between PDK1</A> and<SUP> </SUP>wild type p70 S6K-T2 kinase was detected (Fig. <a href="#F6">6</a>).



<BR CLEAR=ALL><A NAME="F6"><!-- FIG 6 --></A>

<P><CENTER><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/274/52/37400/F6">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=186 SRC="/content/vol274/issue52/images/small/bc4993497006.gif"></A><BR>

<STRONG>View larger version</STRONG> (16K):
<BR><NOBR><A HREF="/cgi/content/full/274/52/37400/F6">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/274/52/37400/F6"
onClick="startTarget('F6', 590, 609); this.href='/cgi/content-nw/full/274/52/37400/F6'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F6">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 6. &nbsp;</STRONG>

<B>Quantitative analysis of the binding of </B><B>PDK1</B></A><B>
to p70 S6K.</B> Surface plasmon resonance measurements were carried
out on a BiaCore instrument as described under "Experimental
Procedures." His-PDK1 was injected at the indicated concentrations
over (<I>A</I>) 2000&nbsp;RUs of p70 S6K-T2 (<I>closed squares</I>)
or 412E-p70 S6K-T2 (<I>closed circles</I>), which was immobilized
by amine coupling to a CM5 Sensorchip. Experiments carried out in the
presence of either 10&nbsp;&#181;<font size=-1>M</font> wild type PIF</A> peptide
(<I>octagons</I>) or 10&nbsp;&#181;<font size=-1>M</font> D978A mutant PIF</A> peptide
(<I>triangles</I>) are indicated. The responses at steady state
binding were recorded. All data are single determinations from a
representative experiment that was repeated at least three times with
similar results. The data on the binding of wild type p70 S6K to PDK1</A>
at concentrations above 2&nbsp;&#181;<font size=-1>M</font> are not shown, as our
analysis of the data suggested that nonspecific protein binding was
contributing to part of the observed binding response under these
conditions.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 6 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Recent work has shown a high affinity-interaction between PIF</A> and
the kinase domain of PDK1</A>, which enhances the rate at which<SUP> </SUP>PDK1</A>
phosphorylates PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and allows it to phosphorylate Ser-473<SUP> </SUP>as well as
Thr-308. In this study we have made the surprising<SUP> </SUP>observation that PIF</A>
prevents PDK1</A> from phosphorylating p70 S6K<SUP> </SUP>(Figs. <a href="#F1">1</a> and <a href="#F2">2</a>), and
expression of PIF</A> in 293&nbsp;cells prevents the<SUP> </SUP>IGF1-induced activation of
p70 S6K (Fig. <a href="#F3">3</a>) without affecting<SUP> </SUP>the activation of PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> (Fig. <a href="#F4">4</a>).
Mutant forms of PIF</A>, which interact<SUP> </SUP>weakly with PDK1</A>, were much less
effective at inhibiting the phosphorylation<SUP> </SUP>of p70 S6K by PDK1</A> <I>in
vitro</I> or at inhibiting the IGF1-induced<SUP> </SUP>activation of the p70 S6K.
These observations could be explained<SUP> </SUP>if p70 S6K, but not PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">,
needed to interact with PDK1</A> at a site<SUP> </SUP>that overlaps with the PIF</A>
binding site before p70 S6K can become<SUP> </SUP>phosphorylated by PDK1</A>. This
conclusion is supported by the findings<SUP> </SUP>in Fig. <a href="#F6">6</a> that p70 S6K does
interact with PDK1</A>, and this interaction<SUP> </SUP>is abolished in the presence
of the PIF</A> peptide. The finding that<SUP> </SUP>the T412E mutant form of p70 S6K
interacts with PDK1</A> with higher<SUP> </SUP>affinity than the wild type enzyme may
also explain why the T412E<SUP> </SUP>mutant of p70 S6K was observed in previous
studies to be a better<SUP> </SUP>substrate for PDK1</A> than the wild type or T412A
mutant of p70 S6K<SUP> </SUP>(<A HREF="#B7">7</A>, <A HREF="#B8">8</A>). Phosphorylation of PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> by PDK1</A> is not
inhibited<SUP> </SUP>by the presence of PIF</A>, and we could not detect any
significant<SUP> </SUP>interaction between PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PDK1</A> <I>in vitro</I> by
surface plasmon<SUP> </SUP>resonance (data not shown). As PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> and PDK1</A> both
interact with<SUP> </SUP>3-phosphoinositides through their pleckstrin homology
domains,<SUP> </SUP>it is possible that this is the primary determinant for
co-localizing<SUP> </SUP>these molecules at the plasma membrane and hence allowing
PDK1</A><SUP> </SUP>to phosphorylate PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha ">. In contrast, substrates for PDK1</A> such as<SUP> </SUP>p70 S6K, which do not interact with 3-phosphoinositides, may
actually<SUP> </SUP>need to interact with PDK1</A> with relatively high affinity
before<SUP> </SUP>they can become phosphorylated. Previous evidence that PDK1</A> is<SUP> </SUP>an activator of p70 S6K rested largely on the demonstration that<SUP> </SUP>PDK1</A>
phosphorylates and activates p70 S6K <I>in vitro</I> and in
cotransfection<SUP> </SUP>experiments. The finding in this study that expression
of PIF</A><SUP> </SUP>can prevent the activation of p70 S6K <I>in vivo</I>,
presumably by binding<SUP> </SUP>to PDK1</A>, provides further evidence that PDK1</A> is
required for the<SUP> </SUP>activation of p70 S6K in<SUP> </SUP>cells.
    
    </P>

    
    <P>Interaction with PIF</A> converts PDK1</A> into a kinase that is capable of
phosphorylating both Thr-308 and Ser-473 sites of PKB</A>.<SUP> </SUP>This
demonstrates that PDK1</A> has the intrinsic ability to phosphorylate<SUP> </SUP>the
residue in the T-loop as well as the PDK2 motif of at least<SUP> </SUP>one AGC
kinase family member. As the residues surrounding Thr-412<SUP> </SUP>of p70 S6K
are highly homologous to those surrounding Ser-473<SUP> </SUP>of PKB</A>, it could be
argued that PDK1</A>, perhaps in complex with<SUP> </SUP>another protein(s), would
also possess the intrinsic ability to<SUP> </SUP>phosphorylate p70 S6K at Thr-252
and Thr-412. The present study<SUP> </SUP>supports this hypothesis because first,
overexpression of wild<SUP> </SUP>type PDK1</A> triggers the phosphorylation of p70
S6K at Thr-412 (Fig.<SUP> </SUP><a href="#F5">5</a><I>A</I>). Second, expression with PIF</A>
prevents the IGF1-induced phosphorylation<SUP> </SUP>of p70 S6K at Thr-412 in
cells (Fig. <a href="#F3">3</a><I>A</I>). Third, the PDK1-catalyzed<SUP> </SUP>phosphorylation
of p70 S6K at Thr-412 <I>in vitro</I> was prevented by<SUP> </SUP>PIF</A> (Fig.
<a href="#F2">2</a>). Finally, the overexpression of a kinase-dead mutant<SUP> </SUP>of PDK1</A> in
cells not only prevented the activation of p70 S6K,<SUP> </SUP>as reported by
others (<A HREF="#B8">8</A>), but also prevented the phosphorylation<SUP> </SUP>of p70 S6K at
Thr-412 (Fig. <a href="#F5">5</a>). Taken together, the data suggest<SUP> </SUP>that PDK1</A> could
phosphorylate p70 S6K at Thr-412 <I>in vivo</I>. As PDK1</A><SUP> </SUP>phosphorylation of Thr-412 of p70 S6K <I>in vitro</I> is not
dependent<SUP> </SUP>upon 3-phosphoinositde lipids, it is possible that the
sensitivity<SUP> </SUP>of PDK1</A> to these lipids in cells is conferred by the
interaction<SUP> </SUP>of PDK1</A> with another protein. In this respect it should be
recalled<SUP> </SUP>that the interaction of PDK1</A> with PIF</A> enables PDK1</A> to be
directly<SUP> </SUP>activated by 3-phosphoinositides (<A HREF="#B22">22</A>). It is also possible
that<SUP> </SUP>a PDK1-interacting protein(s) could increase the rate at which<SUP> </SUP>PDK1</A> phosphorylates both Thr-252 and Thr-412 of p70<SUP> </SUP>S6K.
    
    </P>

    
    <P>It has been recently reported that catalytically inactive mutants of
PKC<IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda "> (<A HREF="#B30">30</A>) and PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> (<A HREF="#B29">29</A>) antagonize the ability of<SUP> </SUP>agonists to
activate p70 S6K in cells. These observations were<SUP> </SUP>interpreted as
indicating that PKC<IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda ">/PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> may have a role in activating<SUP> </SUP>p70 S6K in
cells. However, PKC<IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda "> and PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> are both AGC kinase family<SUP> </SUP>members,
which are likely to be activated by PDK1</A> <I>in vivo</I>, and<SUP> </SUP>possess an acidic residue rather than Ser/Thr in their PDK2 consensus<SUP> </SUP>motif. Furthermore, PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta ">, like PIF</A> has been shown to interact<SUP> </SUP>directly with the kinase domain of PDK1</A> (<A HREF="#B16">16</A>, <A HREF="#B18">18</A>). It is therefore<SUP> </SUP>possible that both PKC<IMG SRC="/math/12pt/normal/lambda.gif" ALIGN=BASELINE ALT="lambda "> and PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> interact with PDK1</A> in the same<SUP> </SUP>way
as PIF</A> and so prevent PDK1</A> from inducing the activation of<SUP> </SUP>p70 S6K.
Recent work also implicated PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> in mediating a rapamycin-sensitive<SUP> </SUP>phosphorylation of the novel PKC</A> isoform (PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta ">) at the residue<SUP> </SUP>equivalent to Thr-412 of p70 S6K (<A HREF="#B31">31</A>). This study did not, however,<SUP> </SUP>rule out the possibility that PDK1</A> complexed to PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta "> acquires<SUP> </SUP>the
ability to phosphorylate PKC<IMG SRC="/math/12pt/normal/delta.gif" ALIGN=BASELINE ALT="delta "> at this residue, rather than<SUP> </SUP>PKC<IMG SRC="/math/12pt/normal/zeta.gif" ALIGN=BASELINE ALT="zeta ">
itself directly phosphorylating this residue. To complicate<SUP> </SUP>matters
further, it has also recently been shown that conventional<SUP> </SUP>PKC<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> is
capable of autophosphorylating itself at the residue equivalent<SUP> </SUP>to
Thr-412 of p70 S6K (18,&nbsp;reviewed in Ref. <A HREF="#B33">33</A>). Sabatini and<SUP> </SUP>colleagues
(<A HREF="#B34">34</A>, <A HREF="#B35">35</A>) have reported that mTOR phosphorylates<SUP> </SUP>p70 S6K directly at
Thr-412. However, much recent evidence suggests<SUP> </SUP>that the ability of
rapamycin, an inhibitor of the mTOR kinase,<SUP> </SUP>to suppress the activity of
p70 S6K is mediated primarily through<SUP> </SUP>the rapamycin-induced activation
of an mTOR-regulated protein<SUP> </SUP>phosphatase, which dephosphorylates p70
S6K (<A HREF="#B32">32</A>, <A HREF="#B36">36</A>, <A HREF="#B37">37</A>).<SUP> </SUP>It will be important to establish whether mTOR or any
other insulin-stimulated<SUP> </SUP>kinase, which can phosphorylate p70 S6K at
Thr-412, is inhibited<SUP> </SUP>by PIF</A>.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We thank Dr. Andrew Paterson for preparation
of His-PDK1 and Agnieszka Kieloch for culture of 293&nbsp;cells. We also
thank Pfizer,<SUP> </SUP>Smith Kline-Beecham, Astra Zeneca, and Novo-Nordisc for<SUP> </SUP>support.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This work was supported by the British Diabetic Association
(to D.&nbsp;R.&nbsp;A.) and Medical Research Council of the United Kingdom<SUP> </SUP>(D.&nbsp;R.&nbsp;A.).The costs of publication of this
article were defrayed<SUP> </SUP>in part by the
payment of page charges. The article
must therefore<SUP> </SUP>be hereby marked
"<I>advertisement</I>" in
accordance with 18&nbsp;U.S.C.<SUP> </SUP>Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN160"><SUP>**</SUP></A>
To whom correspondence should be addressed. Tel.: 44&nbsp;382&nbsp;344241;
Fax: 44&nbsp;382&nbsp;223778; E-mail: dralessi@bad.dundee.ac.uk.

<P>



<A NAME="abb"><!-- comment for mosaic --></A>

<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

p70 S6K, p70 S6
kinase;

PKB, protein kinase B;

PKC, protein kinase C;

PDK1, 3-phosphoinositide-dependent protein kinase-1;

PRK2, protein kinase C-related kinase-2;

PIF, PDK1 interacting fragment;

HA, hemagluttinin;

GST, glutathione <I>S</I>-transferase;

HPLC, high
pressure liquid chromatography;

IGF, insulin-like growth factor.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Proud, C. G.



(1995)

<I>Trends Biochem. Sci</I>
<B>21</B>,
181-185<!-- HIGHWIRE ID="274:52:37400:1" --><A HREF="/cgi/external_ref?access_num=10.1016/0968-0004(96)10016-5&link_type=DOI">[CrossRef]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Lane, H. A.,
Fernandez, A.,
Lamb, N. J.,
 and Thomas, G.



(1993)

<I>Nature</I>
<B>363</B>,
170-172<!-- HIGHWIRE ID="274:52:37400:2" --><A HREF="/cgi/external_ref?access_num=8483501&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8483501&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Jefferies, H. B.&nbsp;J.,
Fumagalli, S.,
Dennis, P. B.,
Reinhard, C.,
Pearson, R. B.,
 and Thomas, G.



(1997)

<I>EMBO J.</I>
<B>16</B>,
3693-3704<!-- HIGHWIRE ID="274:52:37400:3" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=16/12/3693"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Pearson, R. B.,
Dennis, P. B.,
Han, J. W.,
Williamson, N. A.,
Kozma, S. C.,
Wettenhall, R. E.&nbsp;H.,
 and Thomas, G.



(1995)

<I>EMBO J.</I>
<B>14</B>,
5278-5287<!-- HIGHWIRE ID="274:52:37400:4" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Pullen, N.,
 and Thomas, G.



(1998)

<I>FEBS Lett.</I>
<B>410</B>,
78-82<!-- HIGHWIRE ID="274:52:37400:5" --><A HREF="/cgi/external_ref?access_num=10.1016/S0014-5793(97)00323-2&link_type=DOI">[CrossRef]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Weng, Q. P.,
Kozlowski, M.,
Belham, C.,
Zhang, A. H.,
Comb, M. J.,
 and Avruch, J.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
16621-16629<!-- HIGHWIRE ID="274:52:37400:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/26/16621"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
Kozlowski, M. T.,
Weng, Q. P.,
Morrice, N.,
 and Avruch, J.



(1998)

<I>Curr. Biol.</I>
<B>8</B>,
69-81<!-- HIGHWIRE ID="274:52:37400:7" --><A HREF="/cgi/external_ref?access_num=9427642&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9427642&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Pullen, N.,
Dennis, P. B.,
Andjelkovic, M.,
Dufner, A.,
Kozma, S. C.,
Hemmings, B. A.,
 and Thomas, G.



(1998)

<I>Science</I>
<B>279</B>,
707-710<!-- HIGHWIRE ID="274:52:37400:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=279/5351/707"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Alessi, R.,
 and Cohen, P.



(1998)

<I>Curr. Opin. Genet. Dev.</I>
<B>8</B>,
55-62<!-- HIGHWIRE ID="274:52:37400:9" --><A HREF="/cgi/external_ref?access_num=10.1016/S0959-437X(98)80062-2&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9529606&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9529606&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Mellor, H.,
 and Parker, P. J.



(1998)

<I>Biochem. J.</I>
<B>332</B>,
281-292<!-- HIGHWIRE ID="274:52:37400:10" --><A HREF="/cgi/external_ref?access_num=9601053&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9601053&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Webster, M. K.,
Goya, L.,
Ge, Y.,
Maiyar, A. C.,
 and Firestone, G. L.



(1993)

<I>Mol. Cell. Biol.</I>
<B>13</B>,
2031-2040<!-- HIGHWIRE ID="274:52:37400:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=13/4/2031">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Shepherd, R.,
Withers, D. J.,
 and Siddle, K.



(1998)

<I>Biochem. J.</I>
<B>333</B>,
471-479<!-- HIGHWIRE ID="274:52:37400:12" --><A HREF="/cgi/external_ref?access_num=9677303&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9677303&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Belham, C.,
Wu, S. L.,
 and Avruch, J.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
R93-R96<!-- HIGHWIRE ID="274:52:37400:13" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80058-X&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10021376&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10021376&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
James, S. R.,
Downes, C. P.,
Holmes, A. B.,
Gaffney, P. R.&nbsp;J.,
Reese, C. B.,
 and Cohen, P.



(1997)

<I>Curr. Biol.</I>
<B>7</B>,
261-269<!-- HIGHWIRE ID="274:52:37400:14" --><A HREF="/cgi/external_ref?access_num=9094314&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9094314&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Stokoe, D.,
Stephens, L. R.,
Copeland, T.,
Gaffney, P. R.,
Reese, C. B.,
Painter, G. F.,
Holmes, A. B.,
McCormick, F.,
 and Hawkins, P. T.



(1997)

<I>Science</I>
<B>277</B>,
567-570<!-- HIGHWIRE ID="274:52:37400:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=277/5325/567"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

LeGood, J. A.,
Ziegler, H.,
Parekh, D. B.,
Alessi, D. R.,
Cohen, P.,
 and Parker, P. J.



(1998)

<I>Science</I>
<B>281</B>,
2042-2045<!-- HIGHWIRE ID="274:52:37400:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=281/5385/2042"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Chou, M. M.,
Hou, W. M.,
Johnson, J.,
Graham, L. K.,
Lee, M. H.,
Chen, C. S.,
Newton, A. C.,
Schaffhausen, B. S.,
 and Toker, A.



(1998)

<I>Curr. Biol.</I>
<B>8</B>,
1069-1077<!-- HIGHWIRE ID="274:52:37400:17" --><A HREF="/cgi/external_ref?access_num=9768361&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9768361&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Dutil, E. M.,
Toker, A.,
 and Newton, A. C.



(1998)

<I>Curr. Biol.</I>
<B>8</B>,
1366-1375<!-- HIGHWIRE ID="274:52:37400:18" --><A HREF="/cgi/external_ref?access_num=9889098&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9889098&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Kobayashi, T.,
 and Cohen, P.



(1999)

<I>Biochem. J.</I>
<B>339</B>,
319-328<!-- HIGHWIRE ID="274:52:37400:19" --><A HREF="/cgi/external_ref?access_num=10.1042/0264-6021:3390319&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10191262&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10191262&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Park, J.,
Leong, M. L.&nbsp;L.,
Buse, P.,
Maiyar, A. C.,
Firestone, G. L.,
 and Hemmings, B. A.



(1999)

<I>EMBO J.</I>
<B>18</B>,
3024-3033<!-- HIGHWIRE ID="274:52:37400:20" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=18/11/3024"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Cheng, D.,
Ma, Y. L.,
Moore, M.,
Hemmings, B. A.,
 and Taylor, S. S.



(1998)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>95</B>,
9849-9854<!-- HIGHWIRE ID="274:52:37400:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/17/9849"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Balendran, A.,
Casamayor, A.,
Deak, M.,
Paterson, A.,
Gaffney, P.,
Currie, R.,
Downes, C. P.,
 and Alessi, D. R.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
393-404<!-- HIGHWIRE ID="274:52:37400:22" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80186-9&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10226025&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10226025&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
Caudwell, F. B.,
Andjelkovic, M.,
Hemmings, B. A.,
 and Cohen, P.



(1996)

<I>FEBS Lett.</I>
<B>399</B>,
333-338<!-- HIGHWIRE ID="274:52:37400:23" --><A HREF="/cgi/external_ref?access_num=10.1016/S0014-5793(96)01370-1&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8985174&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=8985174&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Leighton, I. A.,
Dalby, K. N.,
Caudwell, F. B.,
Cohen, T. W.,
 and Cohen, P.



(1995)

<I>FEBS Lett.</I>
<B>375</B>,
289-293<!-- HIGHWIRE ID="274:52:37400:24" --><A HREF="/cgi/external_ref?access_num=10.1016/0014-5793(95)01170-J&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=7498520&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=7498520&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Walker, K. S.,
Deak, M.,
Paterson, A.,
Hudson, K.,
Cohen, P.,
 and Alessi, D. R.



(1998)

<I>Biochem. J.</I>
<B>331</B>,
299-308<!-- HIGHWIRE ID="274:52:37400:25" --><A HREF="/cgi/external_ref?access_num=9512493&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9512493&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
Deak, M.,
Casamayor, A.,
Caudwell, F. B.,
Morrice, N.,
Norman, D. G.,
Gaffney, P.,
Reese, C. B.,
MacDougall, C. N.,
Harbison, D.,
Ashworth, A.,
 and Bownes, M.



(1997)

<I>Curr. Biol.</I>
<B>7</B>,
776-789<!-- HIGHWIRE ID="274:52:37400:26" --><A HREF="/cgi/external_ref?access_num=9368760&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9368760&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Casamayor, A.,
Morrice, N.,
 and Alessi, D. R.



(1999)

<I>Biochem. J.</I>
<B>342</B>,
287-292<!-- HIGHWIRE ID="274:52:37400:27" --><A HREF="/cgi/external_ref?access_num=10.1042/0264-6021:3420287&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10455013&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10455013&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
Andjelkovic, M.,
Caudwell, F. B.,
Cron, P.,
Morrice, N.,
Cohen, P.,
 and Hemmings, B.



(1996)

<I>EMBO J.</I>
<B>15</B>,
6541-6551<!-- HIGHWIRE ID="274:52:37400:28" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=15/23/6541">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Romanelli, A.,
Martin, K. A.,
Toker, A.,
 and Blenis, J.



(1999)

<I>Mol. Cell. Biol.</I>
<B>19</B>,
2921-2928<!-- HIGHWIRE ID="274:52:37400:29" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=19/4/2921"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B30">30.</a>
    <TD VALIGN=TOP>

Akimoto, K.,
Nakaya, M.,
Yamanaka, T.,
Tanaka, J.,
Matsuda, S.,
Weng, Q. P.,
Avruch, J.,
 and Ohno, S.



(1998)

<I>Biochem. J.</I>
<B>273</B>,
16621-16629<!-- HIGHWIRE ID="274:52:37400:30" --><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B31">31.</a>
    <TD VALIGN=TOP>

Ziegler, W. H.,
Parekh, D. B.,
Le Good, J. A.,
Whelan, R. D.&nbsp;H.,
Kelly, J. J.,
Frech, M.,
Hemmings, B. A.,
 and Parker, P. J.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
522-529<!-- HIGHWIRE ID="274:52:37400:31" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80236-X&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10339425&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10339425&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B32">32.</a>
    <TD VALIGN=TOP>

Sabatini, D. M.,
Barrow, R. K.,
Blackshaw, S.,
Burnett, P. E.,
Lai, M. M.,
Field, M. E.,
Bahr, B. A.,
Kirsch, J.,
Betz, H.,
 and Snyde, S. H.



(1999)

<I>Science</I>
<B>284</B>,
1161-1164<!-- HIGHWIRE ID="274:52:37400:32" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=284/5417/1161"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B33">33.</a>
    <TD VALIGN=TOP>

Peterson, R. T.,
 and Schreiber, S. L.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
R521-524<!-- HIGHWIRE ID="274:52:37400:33" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80326-1&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10421571&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10421571&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B34">34.</a>
    <TD VALIGN=TOP>

Burnett, P. E.,
Barrow, R. K.,
Cohen, N. A.,
Snyder, S. H.,
 and Sabatini, D. M.



(1998)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>95</B>,
1432-1437<!-- HIGHWIRE ID="274:52:37400:34" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/4/1432"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B35">35.</a>
    <TD VALIGN=TOP>

Isotani, S.,
Hara, K.,
Tokunaga, C.,
Inoue, H.,
Avruch, J.,
 and Yonezawa, K.



(1999)

<I>J. Biol. Chem</I>
<B>274</B>,
34493-34498<!-- HIGHWIRE ID="274:52:37400:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=274/48/34493"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B36">36.</a>
    <TD VALIGN=TOP>

Hara, K.,
Yonezawa, K.,
Weng, Q. P.,
Kozlowski, M. T.,
Belham, C.,
 and Avruch, J.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
14484-14494<!-- HIGHWIRE ID="274:52:37400:36" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/23/14484"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->; Correction (1998) <I>J.&nbsp;Biol. Chem.</I> <B>273,</B>&nbsp;22160
    </TR>
<TR><TD VALIGN=TOP><a name="B37">37.</a>
    <TD VALIGN=TOP>

Peterson, R. T.,
Desai, B. N.,
Hardwick, J. S.,
 and Schreiber, S. L.



(1999)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>96</B>,
4438-4442<!-- HIGHWIRE ID="274:52:37400:37" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=96/8/4438"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 1999 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Pattingre, C. Bauvy, and P. Codogno<BR>
	<STRONG>Amino Acids Interfere with the ERK1/2-dependent Control of Macroautophagy by Controlling the Activation of Raf-1 in Human Colon Cancer HT-29 Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;9,&nbsp;2003;
	278(19):
	16667 - 16674.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/19/16667">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/19/16667">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/19/16667">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	O. J. Shah, S. Ghosh, and T. Hunter<BR>
	<STRONG>Mitotic Regulation of Ribosomal S6 Kinase 1 Involves Ser/Thr, Pro Phosphorylation of Consensus and Non-consensus Sites by Cdc2</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;2,&nbsp;2003;
	278(18):
	16433 - 16442.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/18/16433">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/18/16433">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/18/16433">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.brjpharmacol.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.brjpharmacol.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.brjpharmacol.org"><IMG ALT="Br. J. Pharmacol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/brjpharmacol.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Matsuoka, Y. Nagahara, M. Ikekita, and T. Shinomiya<BR>
	<STRONG>A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells</STRONG><BR>
	
		
			Br. J. Pharmacol.,
		
	
        
        April&nbsp;7,&nbsp;2003;
	138(7):
	1303 - 1312.
<BR>
<A HREF="http://www.brjpharmacol.org/cgi/content/abstract/138/7/1303">[Abstract]</A>

<A HREF="http://www.brjpharmacol.org/cgi/content/full/138/7/1303">[Full Text]</A>
<A HREF="http://www.brjpharmacol.org/cgi/reprint/138/7/1303">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajpgi.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpgi.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajpgi.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajpgi.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. F. Kuemmerle<BR>
	<STRONG>IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase</STRONG><BR>
	
		
			Am J Physiol Gastrointest Liver Physiol,
		
	
        
        March&nbsp;1,&nbsp;2003;
	284(3):
	G411 - 422.
<BR>
<A HREF="http://ajpgi.physiology.org/cgi/content/abstract/284/3/G411">[Abstract]</A>

<A HREF="http://ajpgi.physiology.org/cgi/content/full/284/3/G411">[Full Text]</A>
<A HREF="http://ajpgi.physiology.org/cgi/reprint/284/3/G411">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Romanelli, V. C. Dreisbach, and J. Blenis<BR>
	<STRONG>Characterization of Phosphatidylinositol 3-Kinase-dependent Phosphorylation of the Hydrophobic Motif Site Thr389 in p70 S6 Kinase 1</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;25,&nbsp;2002;
	277(43):
	40281 - 40289.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/43/40281">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/43/40281">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/43/40281">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://cancerres.aacrjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://cancerres.aacrjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://cancerres.aacrjournals.org"><IMG ALT="Cancer Res" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/canres.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	C. Huang, J. Li, Q. Ke, S. S. Leonard, B.-H. Jiang, X.-S. Zhong, M. Costa, V. Castranova, and X. Shi<BR>
	<STRONG>Ultraviolet-induced Phosphorylation of p70S6K at Thr389 and Thr421/Ser424 Involves Hydrogen Peroxide and Mammalian Target of Rapamycin but not Akt and Atypical Protein Kinase C</STRONG><BR>
	
		
			Cancer Res.,
		
	
        
        October&nbsp;15,&nbsp;2002;
	62(20):
	5689 - 5697.
<BR>
<A HREF="http://cancerres.aacrjournals.org/cgi/content/abstract/62/20/5689">[Abstract]</A>

<A HREF="http://cancerres.aacrjournals.org/cgi/content/full/62/20/5689">[Full Text]</A>
<A HREF="http://cancerres.aacrjournals.org/cgi/reprint/62/20/5689">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Egawa, H. Maegawa, K. Shi, T. Nakamura, T. Obata, T. Yoshizaki, K. Morino, S. Shimizu, Y. Nishio, E. Suzuki, and A. Kashiwagi<BR>
	<STRONG>Membrane Localization of 3-Phosphoinositide-dependent Protein Kinase-1 Stimulates Activities of Akt and Atypical Protein Kinase C but Does Not Stimulate Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;11,&nbsp;2002;
	277(41):
	38863 - 38869.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/41/38863">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/41/38863">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/41/38863">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	E. A. Goncharova, D. A. Goncharov, A. Eszterhas, D. S. Hunter, M. K. Glassberg, R. S. Yeung, C. L. Walker, D. Noonan, D. J. Kwiatkowski, M. M. Chou, R. A. Panettieri Jr., and V. P. Krymskaya<BR>
	<STRONG>Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation. A ROLE FOR THE TSC2 TUMOR SUPPRESSOR GENE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS (LAM)</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;23,&nbsp;2002;
	277(34):
	30958 - 30967.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/34/30958">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/34/30958">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/34/30958">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.ejbiochem.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.ejbiochem.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.ejbiochem.org"><IMG ALT="Eur J Biochem" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ejbiochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	U. Krause, L. Bertrand, L. Maisin, M. Rosa, and L. Hue<BR>
	<STRONG>Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes</STRONG><BR>
	
		
			Eur. J. Biochem.,
		
	
        
        August&nbsp;1,&nbsp;2002;
	269(15):
	3742 - 3750.
<BR>
<A HREF="http://www.ejbiochem.org/cgi/content/abstract/269/15/3742">[Abstract]</A>

<A HREF="http://www.ejbiochem.org/cgi/content/full/269/15/3742">[Full Text]</A>
<A HREF="http://www.ejbiochem.org/cgi/reprint/269/15/3742">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. M. Biondi, D. Komander, C. C. Thomas, J. M. Lizcano, M. Deak, D. R. Alessi, and D. M.F. van Aalten<BR>
	<STRONG>High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        August&nbsp;15,&nbsp;2002;
	21(16):
	4219 - 4228.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/21/16/4219">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/21/16/4219">[Full Text]</A>
<A HREF="http://emboj.oupjournals.org/cgi/reprint/21/16/4219">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajpendo.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpendo.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajpendo.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajpendo.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	C. J. Lynch, B. J. Patson, J. Anthony, A. Vaval, L. S. Jefferson, and T. C. Vary<BR>
	<STRONG>Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue</STRONG><BR>
	
		
			Am J Physiol Endocrinol Metab,
		
	
        
        September&nbsp;1,&nbsp;2002;
	283(3):
	E503 - 513.
<BR>
<A HREF="http://ajpendo.physiology.org/cgi/content/abstract/283/3/E503">[Abstract]</A>

<A HREF="http://ajpendo.physiology.org/cgi/content/full/283/3/E503">[Full Text]</A>
<A HREF="http://ajpendo.physiology.org/cgi/reprint/283/3/E503">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. M. Lizcano, M. Deak, N. Morrice, A. Kieloch, C. J. Hastie, L. Dong, M. Schutkowski, U. Reimer, and D. R. Alessi<BR>
	<STRONG>Molecular Basis for the Substrate Specificity of NIMA-related Kinase-6 (NEK6). EVIDENCE THAT NEK6 DOES NOT PHOSPHORYLATE THE HYDROPHOBIC MOTIF OF RIBOSOMAL S6 PROTEIN KINASE AND SERUM- AND GLUCOCORTICOID-INDUCED PROTEIN KINASE IN VIVO</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;2,&nbsp;2002;
	277(31):
	27839 - 27849.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/31/27839">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/31/27839">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/31/27839">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Arico, S. Pattingre, C. Bauvy, P. Gane, A. Barbat, P. Codogno, and E. Ogier-Denis<BR>
	<STRONG>Celecoxib Induces Apoptosis by Inhibiting 3-Phosphoinositide-dependent Protein Kinase-1 Activity in the Human Colon Cancer HT-29 Cell Line</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;2,&nbsp;2002;
	277(31):
	27613 - 27621.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/31/27613">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/31/27613">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/31/27613">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://cancerres.aacrjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://cancerres.aacrjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://cancerres.aacrjournals.org"><IMG ALT="Cancer Res" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/canres.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	X. Zeng, H. Xu, and R. I. Glazer<BR>
	<STRONG>Transformation of Mammary Epithelial Cells by 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Is Associated with the Induction of Protein Kinase C{alpha}</STRONG><BR>
	
		
			Cancer Res.,
		
	
        
        June&nbsp;1,&nbsp;2002;
	62(12):
	3538 - 3543.
<BR>
<A HREF="http://cancerres.aacrjournals.org/cgi/content/abstract/62/12/3538">[Abstract]</A>

<A HREF="http://cancerres.aacrjournals.org/cgi/content/full/62/12/3538">[Full Text]</A>
<A HREF="http://cancerres.aacrjournals.org/cgi/reprint/62/12/3538">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Saitoh, N. Pullen, P. Brennan, D. Cantrell, P. B. Dennis, and G. Thomas<BR>
	<STRONG>Regulation of an Activated S6 Kinase 1 Variant Reveals a Novel Mammalian Target of Rapamycin Phosphorylation Site</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;31,&nbsp;2002;
	277(22):
	20104 - 20112.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/22/20104">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/22/20104">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/22/20104">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajpendo.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpendo.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajpendo.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajpendo.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	T. Yamada, H. Katagiri, T. Asano, M. Tsuru, K. Inukai, H. Ono, T. Kodama, M. Kikuchi, and Y. Oka<BR>
	<STRONG>Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes</STRONG><BR>
	
		
			Am J Physiol Endocrinol Metab,
		
	
        
        June&nbsp;1,&nbsp;2002;
	282(6):
	E1385 - 1394.
<BR>
<A HREF="http://ajpendo.physiology.org/cgi/content/abstract/282/6/E1385">[Abstract]</A>

<A HREF="http://ajpendo.physiology.org/cgi/content/full/282/6/E1385">[Full Text]</A>
<A HREF="http://ajpendo.physiology.org/cgi/reprint/282/6/E1385">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Shi, J.-h. Hsu, L. Hu, J. Gera, and A. Lichtenstein<BR>
	<STRONG>Signal Pathways Involved in Activation of p70S6K and Phosphorylation of 4E-BP1 following Exposure of Multiple Myeloma Tumor Cells to Interleukin-6</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;3,&nbsp;2002;
	277(18):
	15712 - 15720.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/18/15712">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/18/15712">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/18/15712">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jneurosci.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jneurosci.org"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	P. P. Sanna, M. Cammalleri, F. Berton, C. Simpson, R. Lutjens, F. E. Bloom, and W. Francesconi<BR>
	<STRONG>Phosphatidylinositol 3-Kinase Is Required for the Expression But Not for the Induction or the Maintenance of Long-Term Potentiation in the Hippocampal CA1 Region</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        May&nbsp;1,&nbsp;2002;
	22(9):
	3359 - 3365.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/22/9/3359">[Abstract]</A>

<A HREF="http://www.jneurosci.org/cgi/content/full/22/9/3359">[Full Text]</A>
<A HREF="http://www.jneurosci.org/cgi/reprint/22/9/3359">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Gonzalez-Garcia, E. Garrido, C. Hernandez, B. Alvarez, C. Jimenez, D. A. Cantrell, N. Pullen, and A. C. Carrera<BR>
	<STRONG>A New Role for the p85-Phosphatidylinositol 3-Kinase Regulatory Subunit Linking FRAP to p70 S6 Kinase Activation</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;11,&nbsp;2002;
	277(2):
	1500 - 1508.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/2/1500">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/2/1500">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/2/1500">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. Park, M. M. Hill, D. Hess, D. P. Brazil, J. Hofsteenge, and B. A. Hemmings<BR>
	<STRONG>Identification of Tyrosine Phosphorylation Sites on 3-Phosphoinositide-dependent Protein Kinase-1 and Their Role in Regulating Kinase Activity</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;5,&nbsp;2001;
	276(40):
	37459 - 37471.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/40/37459">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/40/37459">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/40/37459">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	X. Wang, W. Li, M. Williams, N. Terada, D. R. Alessi, and C. G. Proud<BR>
	<STRONG>Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        August&nbsp;15,&nbsp;2001;
	20(16):
	4370 - 4379.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/20/16/4370">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/20/16/4370">[Full Text]</A>
<A HREF="http://emboj.oupjournals.org/cgi/reprint/20/16/4370">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. M. Biondi, A. Kieloch, R. A. Currie, M. Deak, and D. R. Alessi<BR>
	<STRONG>The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        August&nbsp;15,&nbsp;2001;
	20(16):
	4380 - 4390.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/20/16/4380">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/20/16/4380">[Full Text]</A>
<A HREF="http://emboj.oupjournals.org/cgi/reprint/20/16/4380">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. Zhang, Z. Dong, M. Nomura, S. Zhong, N. Chen, A. M. Bode, and Z. Dong<BR>
	<STRONG>Signal Transduction Pathways Involved in Phosphorylation and Activation of p70S6K Following Exposure to UVA Irradiation</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        June&nbsp;8,&nbsp;2001;
	276(24):
	20913 - 20923.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/24/20913">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/24/20913">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/24/20913">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	G. P. Sapkota, A. Kieloch, J. M. Lizcano, S. Lain, J. S. C. Arthur, M. R. Williams, N. Morrice, M. Deak, and D. R. Alessi<BR>
	<STRONG>Phosphorylation of the Protein Kinase Mutated in Peutz-Jeghers Cancer Syndrome, LKB1/STK11, at Ser431 by p90RSK and cAMP-dependent Protein Kinase, but Not Its Farnesylation at Cys433, Is Essential for LKB1 to Suppress Cell Growth</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;25,&nbsp;2001;
	276(22):
	19469 - 19482.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/22/19469">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/22/19469">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/22/19469">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Matsumoto, W. Ogawa, Y. Hino, K. Furukawa, Y. Ono, M. Takahashi, M. Ohba, T. Kuroki, and M. Kasuga<BR>
	<STRONG>Inhibition of Insulin-induced Activation of Akt by a Kinase-deficient Mutant of the epsilon  Isozyme of Protein Kinase C</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        April&nbsp;20,&nbsp;2001;
	276(17):
	14400 - 14406.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/17/14400">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/17/14400">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/17/14400">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. A. Martin, S. S. Schalm, C. Richardson, A. Romanelli, K. L. Keon, and J. Blenis<BR>
	<STRONG>Regulation of Ribosomal S6 Kinase 2 by Effectors of the Phosphoinositide 3-Kinase Pathway</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;9,&nbsp;2001;
	276(11):
	7884 - 7891.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/11/7884">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/11/7884">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/11/7884">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jneurosci.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jneurosci.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jneurosci.org"><IMG ALT="J. Neurosci." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jneuro.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Khan, A. M. Pepio, and W. S. Sossin<BR>
	<STRONG>Serotonin Activates S6 Kinase in a Rapamycin-Sensitive Manner in Aplysia Synaptosomes</STRONG><BR>
	
		
			J. Neurosci.,
		
	
        
        January&nbsp;15,&nbsp;2001;
	21(2):
	382 - 391.
<BR>
<A HREF="http://www.jneurosci.org/cgi/content/abstract/21/2/382">[Abstract]</A>

<A HREF="http://www.jneurosci.org/cgi/content/full/21/2/382">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. L. Armstrong, S. M. Bonavaud, B. J. Toole, and S. J. Yeaman<BR>
	<STRONG>Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        January&nbsp;5,&nbsp;2001;
	276(2):
	952 - 956.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/2/952">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/2/952">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/2/952">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	B. K. Law, M. E. Waltner-Law, A. J. Entingh, A. Chytil, M. E. Aakre, P. Norgaard, and H. L. Moses<BR>
	<STRONG>Salicylate-induced Growth Arrest Is Associated with Inhibition of p70s6k and Down-regulation of c-Myc, Cyclin D1, Cyclin A, and Proliferating Cell Nuclear Antigen</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        December&nbsp;1,&nbsp;2000;
	275(49):
	38261 - 38267.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/275/49/38261">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/275/49/38261">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/275/49/38261">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Koh, K. H. Lee, D. Kim, S. Kim, J. W. Kim, and J. Chung<BR>
	<STRONG>Inhibition of Akt and Its Anti-apoptotic Activities by Tumor Necrosis Factor-induced Protein Kinase C-related Kinase 2 (PRK2) Cleavage</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;27,&nbsp;2000;
	275(44):
	34451 - 34458.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/275/44/34451">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/275/44/34451">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/275/44/34451">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.ejbiochem.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.ejbiochem.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.ejbiochem.org"><IMG ALT="Eur J Biochem" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ejbiochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	O. Meyuhas<BR>
	<STRONG>Synthesis of the translational apparatus is regulated at the translational level</STRONG><BR>
	
		
			Eur. J. Biochem.,
		
	
        
        November&nbsp;1,&nbsp;2000;
	267(21):
	6321 - 6330.
<BR>
<A HREF="http://www.ejbiochem.org/cgi/content/abstract/267/21/6321">[Abstract]</A>

<A HREF="http://www.ejbiochem.org/cgi/content/full/267/21/6321">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://jvi.asm.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jvi.asm.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://jvi.asm.org"><IMG ALT="J. Virol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jvi.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	F. Scholle, K. M. Bendt, and N. Raab-Traub<BR>
	<STRONG>Epstein-Barr Virus LMP2A Transforms Epithelial Cells, Inhibits Cell Differentiation, and Activates Akt</STRONG><BR>
	
		
			J. Virol.,
		
	
        
        November&nbsp;15,&nbsp;2000;
	74(22):
	10681 - 10689.
<BR>
<A HREF="http://jvi.asm.org/cgi/content/abstract/74/22/10681">[Abstract]</A>

<A HREF="http://jvi.asm.org/cgi/content/full/74/22/10681">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Balendran, R. M. Biondi, P. C. F. Cheung, A. Casamayor, M. Deak, and D. R. Alessi<BR>
	<STRONG>A 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Docking Site Is Required for the Phosphorylation of Protein Kinase Czeta  (PKCzeta ) and PKC-related Kinase 2 by PDK1</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        June&nbsp;30,&nbsp;2000;
	275(27):
	20806 - 20813.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/275/27/20806">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/275/27/20806">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/275/27/20806">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. Fr&ouml;din, C. J. Jensen, K. Merienne, and S. Gammeltoft<BR>
	<STRONG>A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        June&nbsp;15,&nbsp;2000;
	19(12):
	2924 - 2934.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/19/12/2924">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/19/12/2924">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://molpharm.aspetjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://molpharm.aspetjournals.org"><IMG ALT="Mol Pharmacol" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/molpharm.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	A. Toker<BR>
	<STRONG>Protein Kinases as Mediators of Phosphoinositide 3-Kinase Signaling</STRONG><BR>
	
		
			Mol. Pharmacol.,
		
	
        
        April&nbsp;1,&nbsp;2000;
	57(4):
	652 - 658.
<BR>


<A HREF="http://www.molpharm.org/cgi/content/full/57/4/652">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. M. Biondi, P. C.F. Cheung, A. Casamayor, M. Deak, R. A. Currie, and D. R. Alessi<BR>
	<STRONG>Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        March&nbsp;1,&nbsp;2000;
	19(5):
	979 - 988.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/19/5/979">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/19/5/979">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/274/52/37400">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/274/52/37400">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;274/52/37400">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/274/52/37400&title=Evidence+That+3-Phosphoinositide-dependent+Protein+Kinase-1+Mediates+Phosphorylation+of+p70+S6+Kinase+in+Vivo+at+Thr-412+as+well+as+Thr-252">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;274/52/37400&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=10601311&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=10601311&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Balendran+A&link_type=AUTHORSEARCH">Balendran, A.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Alessi+DR&link_type=AUTHORSEARCH">Alessi, D. R.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;274/52/37400&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F274%2F52%2F37400"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;274/52/37400">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx -->
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol274/issue52/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 1999 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
